SEC Form D · Amendment · filed October 1, 2015
Euclises Pharmaceuticals, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (19)
John J. Talley · St. Louis, MODirectorRajesh J. Devraj · St. Louis, MOExec · DirectorCharles A. Bolten · St. Louis, MODirectorRobert W. Karr · St. Louis, MOExec · DirectorRobert J. Calcaterra · St. Louis, MODirectorEduardo J. Martinez · St. Louis, MODirectorRobert A. Beardsley · St. Louis, MODirectorRick A. Ryan · St. Louis, MODirectorDerek R. Hayden · Boston, MADirectorBobby W. Sandage, Jr · SAINT LOUIS, MOExec · DirectorGeoff R. Ruddick · George Town, Grand Cayman, Cayman IslandsExec · DirectorBrian S. Burkholder · Grand Cayman, Cayman IslandsExec · DirectorJohn A. Murphy · Boston, MADirectorPaul J. Pitts · Boston, MADirectorTom Rogat · Beachwood, OHDirectorJohn Eaton · Beachwood, OHDirectorLeon Atkinson · Beachwood, OHExec · DirectorMichael Goldberg · New York, NYExec · DirectorBobby W. Sandage, Jr · SAINT LOUIS, MOExec · Director Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗